Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;

The impact of COVID-19 on the cascade of care of HCV in the US and China Yee Hui Yeo; Xu Gao; Jian Wang; Qingyu Li; Xingyang Su; Yu Geng; Rui Huang; Chao Wu; Fanpu Ji; Vinay Sundaram; Mazen Noureddin; Maria Buti; Walid S. Ayoub;

One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infection Miriam Torrecillas; Neus Gómez-Muñoz; María Dolores Ocete; Purificación Rubio Cuevas; Moisés Diago Madrid; Enrique Ortega González; Concepción Gimeno Cardona; Miguel García-Deltoro;